Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution

25Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Specific proinflammatory alleles are associated with higher risk of Alzheimer disease (AD) in different onset age. The homozygosis for the A allele of -1082 polymorphism (G/A) of interleukin-10 (IL-10) promotes a higher risk of AD and reduced IL-10 generation in peripheral cells after amyloid stimulation. In this paper we analysed genotype and allele frequencies of this polymorphism in 138 subjects with mild cognitive impairment (MCI) diagnosed, respectively, as amnestic (a-MCI) and multiple impaired cognitive domains (mcd-MCI). The genotype frequencies were similar in a-MCI and AD subjects, whereas in mcd-MCI comparable to controls (AA genotype: 50 in a-MCI, 49.2 in AD, 28.7 in mcd-MCI and 31.8 in controls). Consequently, both allele and genotype distributions were significantly different between a-MCI and mcd-MCI (allele: P =.02, genotype: P

Cite

CITATION STYLE

APA

Annoni, G., Arosio, B., Mastronardi, L., & Vergani, C. (2010). Intereleukin-10 promoter polymorphism in mild cognitive impairment and in its clinical evolution. International Journal of Alzheimer’s Disease. https://doi.org/10.4061/2010/854527

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free